A method of modulating cellular activity

Details for Australian Patent Application No. 2006201939 (hide)

Owner Johnson & Johnson Pharmaceutical Research & Development LLC

Inventors Gamble, Jennifer; Wattenberg, Brian; Barter, Philip; Vadas, Matthew; Pitson, Stuart; Rye, Kerry-Anne; Xia, Pu

Agent Blake Dawson Patent Attorneys

Pub. Number AU-B-2006201939

Parent 2003204254

Filing date 1 May 2006

Wipo publication date 1 June 2006

Acceptance publication date 25 September 2008

International Classifications

A61K 31/13 (2006.01) - Amines, e.g. amantadine

A61K 35/14 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Blood

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

25 May 2006 Complete Application Filed

1 June 2006 Application Open to Public Inspection

  Published as AU-B-2006201939

25 September 2008 Application Accepted

  Published as AU-B-2006201939

22 January 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006201940-Metal cap for traffic surface adapter

2006201938-Buoyance Dynamo